Active and passive immunizations with the streptococcal esterase Sse protect mice against subcutaneous infection with group A streptococci

Infection and Immunity

Volumn 75, Issue 7, 2007, Pages 3651-3657

  Liu, Mengyao ^a   Zhu, Hui ^a   Zhang, Jinlian ^a   Lei, Benfang ^a  

^a MONTANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLBUTYRIC ACID DERIVATIVE; BACTERIAL ANTIGEN; CARBOXYLESTERASE; ESTERASE INHIBITOR; HYDROLASE; NUCLEIC ACID; PROTEIN SSE; RECOMBINANT ENZYME; RECOMBINANT PROTEIN; SERINE; SSE ANTIBODY; UNCLASSIFIED DRUG;

ACTIVE IMMUNIZATION; ADOLESCENT; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GENE; BACTERIAL VIRULENCE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HYDROLYSIS; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PASSIVE IMMUNIZATION; PHARYNGITIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; SEROCONVERSION; SKIN INFECTION; SPY1718 GENE; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION;

ANIMALS; ANIMALS, OUTBRED STRAINS; CYSTEINE ENDOPEPTIDASES; FEMALE; HUMANS; IMMUNIZATION; IMMUNIZATION, PASSIVE; INJECTIONS, SUBCUTANEOUS; MICE; PHARYNGITIS; RECOMBINANT PROTEINS; SEROTYPING; SKIN DISEASES, BACTERIAL; STREPTOCOCCAL INFECTIONS; STREPTOCOCCAL VACCINES; STREPTOCOCCUS PYOGENES;

EID: 34447280868     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00038-07     Document Type: Article

References (35)

1. Beachey, E. H., J. M. Seyer, J. B. Dale, W. A. Simpson, and A. H. Kang. 1981. Type-specific protective immunity evoked by synthetic peptide of Streptococcus pyogenes M protein. Nature 292:457-459.
2. Beres, S. B., G. L. Sylva, K. D. Barbian, B. Lei, J. S. Hoff, N. D. Mammarella, M. Liu, J. C. Smoot, S. F. Porcella, L. D. Parkins, J. K. McCormick, D. Y. M. Leung, P. M. Schlievert, and J. M. Musser. 2002. Genome sequence of a serotype M3 strain of group A Streptococcus: phage-encoded toxins, the high-virulence phenotype, and clone emergence. Proc. Natl. Acad. Sci. USA 99:10078-10083.
3. Bessen, D., and V. A. Fischetti. 1990. Synthetic peptide vaccine against mucosal colonization by group A streptococci. I. Protection against a heterologous M serotype with shared C repeat region epitopes. J. Immunol. 145:1251-1256.
4. Brandt, E. R., K. S. Sriprakash, R. I. Hobb, W. A. Hayman, W. Zeng, M. R. Batzloff, D. C. Jackson, and M. F. Good. 2000. New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population. Nat. Med. 6:455-459.
5. Cunningham, M. W. 2000. Pathogenesis of group A streptococcal infections. Clin. Microbiol. Rev. 13:470-511.
6. Dale, J. B., E. Y. Chiang, S. Liu, H. S. Courtney, and D. L. Hasty. 1999. New protective antigen of group A streptococci. J. Clin. Investig. 103:1261-1268.
7. Dale, J. B., T. Penfound, E. Y. Chiang, V. Long, S. T. Shulman, and B. Beall. 2005. Multivalent group A streptococcal vaccine elicits bactericidal antibodies against variant M subtypes. Clin. Diagn. Lab. Immunol. 12:833-836.
8. Ferretti, J. J., W. M. McShan, D. Ajdic, D. J. Savic, G. Savic, K. Lyon, C. Primeaux, S. Sezate, A. N. Suvorov, S. Kenton, H. S. Lai, S. P. Lin, Y. Qian, H. G. Jia, F. Z. Najar, Q. Ren, H. Zhu, L. Song, J. White, X. Yuan, S. W. Clifton, B. A. Roe, and R. McLaughlin. 2001. Complete genome sequence of an Ml strain of Streptococcus pyogenes. Proc. Natl. Acad. Sci. USA 98:4658-4663.
9. Fischetti, V. A. 2006. Vaccine approaches to protect against group A streptococcal pharyngitis, p. 113-122. In V. A. Fischetti, R. P. Novick, J. J. Ferretti, D. A. Portnoy, and J. I. Rood (ed.), Gram-positive pathogens, 2nd ed. ASM Press, Washington, DC.
10. Guzman, C. A., S. R. Talay, G. Molinari, E. Medina, and G. S. Chhatwal. 1999. Protective immune response against Streptococcus pyogenes in mice after intranasal vaccination with the fibronectin-binding protein SfbI. J. Infect. Dis. 179:901-906.
11. Hayano, S., and A. Tanaka. 1973. Extracellular esterases of group A streptococci. Infect. Immun. 7:561-566.
12. Hayano, S., and A. Tanaka. 1973. Distribution of antibodies to streptococcal esterases in patients with scarlet fever. Extracellular esterases of group A streptococci. Infect. Immun. 15:300-304.
13. Hirst, G. K., and R. C. Lancefield. 1939. Antigenic properties of the type-specific substances derived from group A hemolytic streptococci. J. Exp. Med. 69:425-445.
14. Hoe, N. P., K. Nakashima, D. Grigsby, X. Pan, S. J. Dou, S. Naidich, M. Garcia, E. Kahn, D. Bergmire-Sweat, and J. M. Musser. 1999. Rapid molecular genetic subtyping of serotype M1 group A Streptococcus strains. Emerg. Infect. Dis. 5:254-263.
15. Ji, Y., B. Carlson, A. Kondagunta, and P. P. Cleary. 1997. Intranasal immunization with C5a peptidase prevents nasopharyngeal colonization of mice by the group A Streptococcus. Infect. Immun. 65:2080-2087.
16. Kapur, V., J. T. Maffei, R. S. Greer, L. L. Li, G. J. Adams, and J. M. Musser. 1994. Vaccination with streptococcal extracellular cysteine protease (interleukin-1β convertase) protects mice against challenge with heterologous group A streptococci. Microb. Pathog. 16:443-450.
17. Kawabata, S., E. Kunitomo, Y. Terao, I. Nakagawa, K. Kikuchi, K. Totsuka, and S. Hamada. 2001. Systemic and mucosal immunizations with fibronectin-binding protein FBP54 induce protective immune responses against Streptococcus pyogenes challenge in mice. Infect. Immun. 69:924-930.
18. Lancefield, R. C., and G. E. Perlmann. 1952. Preparation and properties of a protein (R antigen) occurring in streptococci of group A, type 28 and in certain streptococci of other serological groups. J. Exp. Med. 96:83-97.
19. Lei, B., S. Mackie, S. Lukomski, and J. M. Musser. 2000. Identification and immunogenicity of group A Streptococcus culture supernatant proteins. Infect. Immun. 68:6807-6818.
20. Lei, B., F. R. DeLeo, N. P. Hoe, M. R. Graham, S. M. Mackie, R. L. Cole, M. Liu, H. R. Hill, D. E. Low, M. J. Federle, J. R. Scott, and J. M. Musser. 2001. Evasion of human innate and acquired immunity by a bacterial homologue of CD11b that inhibits opsonophagocytosis. Nat. Med. 7:1298-1305.
21. Lei, B., L. M. Laura, H. M. Menning, J. M. Voyich, S. V. Kala, F. R. DeLeo, S. D. Reid, and J. M. Musser. 2002. Identification and characterization of a novel heme-associated cell surface protein made by Streptococcus pyogenes. Infect. Immun. 70:4494-4500.
22. Lei, B., M. Liu, J. M. Voyich, C. I. Prater, S. V. Kala, F. R. DeLeo, and J. M. Musser. 2003. Identification and characterization of HtsA, a second heme-binding protein made by Streptococcus pyogenes. Infect. Immun. 71:5962-5969.
23. Lei, B., M. Liu, G. Chesney, and J. M. Musser. 2004. Extracellular putative lipoproteins made by Streptococcus pyogenes: identification of new potential vaccine candidate antigens. J. Infect. Dis. 189:79-89.
24. Liu, M., T. S. Hanks, J. Zhang, M. J. McClure, D. W. Siemsen, J. L. Elser, M. T. Quinn, and B. Lei. 2006. Defects in ex vivo and in vivo growth and sensitivity to osmotic stress of group A Streptococcus caused by interruption of response regulator gene vicR. Microbiology 152:967-978.
25. Lukomski, S., C. A. Montgomery, J. Rurangirwa, R. S. Geske, J. P. Barrish, G. J. Adams, and J. M. Musser. 1999. Extracellular cysteine protease produced by Streptococcus pyogenes participates in the pathogenesis of invasive skin infection and dissemination in mice. Infect. Immun. 67:1779-1788.
26. McCormick, J. K., T. J. Tripp, S. B. Olmsted, Y. V. Matsuka, P. J. Gahr, D. H. Ohlendorf, and P. M. Schlievert. 2000. Development of streptococcal pyrogenic exotoxin C vaccine toxoids that are protective in the rabbit model of toxic shock syndrome. J. Immunol. 165:2306-2312.
27. McNeil, S. A., S. A. Halperin, J. M. Langley, B. Smith, A. Warren, G. P. Sharratt, D. M. Baxendale, M. A. Reddish, M. C. Hu, S. D. Stroop, J. Linden, L. F. Fries, P. E. Vink, and J. B. Dale. 2005. Safety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adult volunteers. Clin. Infect. Dis. 41:1114-1122.
28. Okazaki, H., M. Igarashi, M. Nishi, M. Tajima, M. Sekiya, S. Okazaki, N. Yahagi, K. Ohashi, K. Tsukamoto, M. Amemiya-Kudo, T. Matsuzaka, H. Shimano, N. Yamada, J. Aoki, R. Morikawa, Y. Takanezawa, H. Arai, R. Nagai, T. Kadowaki, J. Osuga, and S. Ishibashi. 2006. Identification of a novel member of the carboxylesterase family that hydrolyzes triacylglycerol: a potential role in adipocyte lipolysis. Diabetes 55:2091-2097.
29. Roggiani, M., J. A. Stoehr, S. B. Olmsted, Y. V. Matsuka, S. Pillai, D. H. Ohlendorf, and P. M. Schlievert. 2000. Toxoids of streptococcal pyrogenic exotoxin A are protective in rabbit models of streptococcal toxic shock syndrome. Infect. Immun. 68:5011-5017.
30. Schmidt, W. C. 1960. Type-specific antibody formation in man following injection of streptococcal M protein. J. Infect. Dis. 106:250-255.
31. Shirai, K., and R. L. Jackson. 1982. Lipoprotein lipase-catalyzed hydrolysis of p-nitrophenyl butyrate. J. Biol. Chem. 257:1253-1258.
32. Stock, A. H., J. Uriel, and P. Grabar. 1961. Esterase in extracellular concentrates of group A streptococci and the homologous antibody. Nature 192:434-435.
33. Sumby, P., K. D. Barbian, D. J. Gardner, A. R. Whitney, D. M. Welty, R. D. Long, J. R. Bailey, M. J. Parnell, N. P. Hoe, G. G. Adams, F. R. Deleo, and J. M. Musser. 2005. Extracellular deoxyribonuclease made by group A Streptococcus assists pathogenesis by enhancing evasion of the innate immune response. Proc. Natl. Acad. Sci. USA 102:1679-1684.
34. Whitaker, J. R. 1972. The esterases, p. 481-501. In Principles of enzymology for the food sciences. Marcel Dekker, Inc., New York, NY.
35. Zabriskie, J. B., T. Poon-King, M. S. Blake, F. Michon, and M. Yoshinaga. 1997. Phagocytic, serological, and protective properties of streptococcal group A carbohydrate antibodies. Adv. Exp. Med. Biol. 418:917-919.